Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
Marc R. Rosen, MD, Assistant Professor of Otolaryngology – Head and Neck Surgery at Jefferson Medical College, describes the relatively new technique of minimally invasive skull base surgery…
Kim Hunter-Schaedle, PhD, Chief Scientific Officer of the Children’s Tumor Foundation, discusses therapeutic options for neurofibromatosis and their progression from surgery, chemotherapy or bracing/amputation to targeted drug treatments.…
In an article published in July 9, 2009 issue of The New England Journal of Medicine, Dr. Daniel Clarke-Pearson, chair of the department of obstetrics and gynecology at…
Scott Nelson, MD, talks at the 2009 NAMC Conference in Santa Ana Pueblo New Mexico, about how physicians can better communicate with terminally ill patients. Reading: Shama ME,…
Thyroid cancer that has spread to distant sites has a poor prognosis, but an experimental drug that inhibits tumor blood vessel formation can slow disease progression in some…
NEW YORK (Reuters Health) – Definitive chemoradiotherapy is an effective treatment than can be dispensed with no significant toxicity in elderly patients with locally advanced esophageal cancer, according…
A research team led by scientists at MD Anderson Cancer Center report that 2 specific common inheritedgenetic variations are associated with increased risk of lung cancer for smokers…
Levels of two proteins in a woman’s ovarian cancer are strongly associated with her likelihood of survival, a research team led by scientists at The University of Texas…
NEW YORK (Reuters Health) – The incidence of non-Hodgkin’s lymphoma (NHL) is increased somewhat in patients with diabetes, according to results of a meta-analysis published in Diabetes Care…
